NCT01702818

Brief Summary

Women with Hypoactive sexual desire disorder (HSDD) have all measures of testosterone activity comparable to controls but lower levels of dehydroepiandrosterone (DHEA). Although DHEA is a precursor of testosterone it has other actions including involvement in the stress system. It is also linked to mood. This study focuses on measures of childhood stress, current mood and salivary stress hormones, in women with and without HSDD. We hypothesize that low levels of DHEA reflect dysfunction of the neuroendocrine stress response system involving the brain, pituitary and adrenal glands where DHEA is produced.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
324

participants targeted

Target at P75+ for all trials

Timeline
Completed

Started Feb 2012

Longer than P75 for all trials

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

February 1, 2012

Completed
7 months until next milestone

First Submitted

Initial submission to the registry

August 27, 2012

Completed
1 month until next milestone

First Posted

Study publicly available on registry

October 8, 2012

Completed
4.1 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

November 1, 2016

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

November 1, 2016

Completed
Last Updated

October 17, 2018

Status Verified

May 1, 2017

Enrollment Period

4.8 years

First QC Date

August 27, 2012

Last Update Submit

October 15, 2018

Conditions

Keywords

Hypoactive Sexual Desire DisorderHSDDCortisolDHEAStress HormonesSexual DesireMoodSexual FunctionChildhood MaltreatmentChildhood Abuse

Outcome Measures

Primary Outcomes (1)

  • DHEA levels

    DHEA levels derived from saliva samples.

    Data is collected at 4 time points on 3 separate days

Secondary Outcomes (8)

  • Cortisol levels

    Data is collected at 4 time points on 3 separate days

  • Depression

    data is collected at single time point

  • Perceived stress

    data is collected at a single time point

  • Sexual function

    data is collected at a single time point

  • Relationship satisfaction

    data is collected at a single time point

  • +3 more secondary outcomes

Study Arms (2)

HSDD group

Women with a diagnosis of Hypoactive Sexual Desire Disorder (HSDD).

Control Group

Women without a diagnosis of Hypoactive Sexual Desire Disorder (HSDD).

Eligibility Criteria

Age19 Years - 65 Years
Sexfemale
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Women with and without a diagnosis of Hypoactive Sexual Desire Disorder (HSDD).

You may qualify if:

  • (1) diagnosis of HSDD
  • (2) over 19 years of age
  • (3) sexual complaints of low desire of at least 12 months duration.
  • (1) sexually healthy, i.e., must not meet criteria for any sexual dysfunction, as determined by a telephone screening, followed by an in-person structured assessment, the Decreased Sexual Desire Screener (DSDS)
  • (2) over 19 years of age.

You may not qualify if:

  • (1) lack of fluency in English
  • (2) currently meeting DSM-IV-TR diagnostic criteria for major depressive disorder as measured by an in-person, semi-structured interview based on the Major Depressive Disorder Module of the Structured Clinical Interview for DSM-IV-TR (SCID-I
  • (3) current use of prescription drugs such as antidepressants or other medications with known sexual side effects (e.g., glucocorticoids, aromatase inhibitors), or known effects on cortisol metabolism, or use of illicit drugs
  • (4) use of hormone replacement therapy or hormonal contraceptives;
  • (5) a body mass index (BMI) \<18.5 or \>29.9
  • (6) cigarette smoking
  • (7) chronic medical or psychiatric disease with potential to interfere with sexual function (e.g., chronic neurological disease, cardiac and liver disease, eating disorders, anxiety disorders)
  • (8) chronic pain with intercourse not relieved by a vaginal lubricant
  • (9) loss of genital responsiveness
  • (10) significant relationship discord
  • (11) not having a family physician who we could contact if depression is diagnosed during the assessment
  • (12) difficulty in complying with questionnaires or in completing interview.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

British Columbia Centre for Sexual Medicine

Vancouver, British Columbia, V6T 1Z9, Canada

Location

Related Links

Biospecimen

Retention: SAMPLES WITHOUT DNA

saliva samples

MeSH Terms

Conditions

Sexual Dysfunctions, Psychological

Condition Hierarchy (Ancestors)

Mental Disorders

Study Officials

  • Rosemary Basson, MD

    University of British Columbia

    PRINCIPAL INVESTIGATOR
  • Lori A Brotto, PhD

    University of British Columbia

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
observational
Observational Model
OTHER
Time Perspective
CROSS SECTIONAL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Associate Professor

Study Record Dates

First Submitted

August 27, 2012

First Posted

October 8, 2012

Study Start

February 1, 2012

Primary Completion

November 1, 2016

Study Completion

November 1, 2016

Last Updated

October 17, 2018

Record last verified: 2017-05

Locations